File Download

There are no files associated with this item.

Supplementary

Conference Paper: Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based study in Hong Kong. The Endocrine Society’s 105th Annual Meeting, Chicago, June 2023.

TitleRisks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based study in Hong Kong. The Endocrine Society’s 105th Annual Meeting, Chicago, June 2023.
Authors
Lui, DTTang, EHWu, TAu, ICLee, CHWoo, YCTan, KCWong, CK
Issue Date15-Jun-2023
Persistent Identifierhttp://hdl.handle.net/10722/337267

 

DC FieldValueLanguage
dc.contributor.authorLui, DT-
dc.contributor.authorTang, EH-
dc.contributor.authorWu, T-
dc.contributor.authorAu, IC-
dc.contributor.authorLee, CH-
dc.contributor.authorWoo, YC-
dc.contributor.authorTan, KC-
dc.contributor.authorWong, CK-
dc.date.accessioned2024-03-11T10:19:22Z-
dc.date.available2024-03-11T10:19:22Z-
dc.date.issued2023-06-15-
dc.identifier.urihttp://hdl.handle.net/10722/337267-
dc.languageeng-
dc.relation.ispartofThe Endocrine Society’s 105th Annual Meeting (15/06/2023-18/06/2023, Chicago)-
dc.titleRisks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based study in Hong Kong. The Endocrine Society’s 105th Annual Meeting, Chicago, June 2023.-
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats